Tag:
American Enterprise Institute
Latest Headlines
Latest Headlines
One man's foreign-source warning is another's generics bash
"Most unfortunate" is what Roger Bate says of the headline of his opinion piece in last week's Wall Street Journal--"Beware the Risks of Generic Drugs"--because the article "really wasn't about
Chinese chemical inconsistency yields drug 'caveat emptor'
"Most Chinese chemicals are high quality, but poor oversight, weak regulation, and occasional grotesque negligence will likely compromise drug quality," says Roger Bate of the American Enterprise
Study finds fuzzy price/drug-quality link
Fifteen percent of 900 drug samples from developing countries failed at least one quality test and are priced 13 to 18 percent lower than non-failing drugs. The poor-quality/low-price link is as of
